{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:13:32Z","timestamp":1784812412612,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study was designed to investigate the effect of calcineurin inhibitors (CNIs), cyclosporine (CsA), and tacrolimus (Tac) on anthropometrics in kidney transplant recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>111 of 128 adult kidney transplant recipients who received post-transplant CNIs were included in this retrospective study. Anthropometrics were recorded in the pre-transplant and post-transplant 4-year follow-up periods (1<jats:sup>st<\/jats:sup>, 3<jats:sup>rd<\/jats:sup>, 6<jats:sup>th<\/jats:sup>, 12<jats:sup>th<\/jats:sup>, 24<jats:sup>th<\/jats:sup>, 36<jats:sup>th<\/jats:sup> and 48<jats:sup>th<\/jats:sup> months).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to pre-transplant values, significant increases in body weight and body mass index (between 3<jats:sup>rd<\/jats:sup> and 48<jats:sup>th<\/jats:sup> months), waist and hip circumferences (between 1<jats:sup>st<\/jats:sup> and 48<jats:sup>th<\/jats:sup> months), waist-to-hip ratio (between 1<jats:sup>st<\/jats:sup> and 3<jats:sup>rd<\/jats:sup> or 6<jats:sup>th<\/jats:sup> months) and neck circumference (between 1<jats:sup>st<\/jats:sup> and 12<jats:sup>th<\/jats:sup> or 24<jats:sup>th<\/jats:sup> months) were observed in both CsA and Tac groups. A significant increase was noted in post-transplant body fat percentage values for the 3<jats:sup>rd<\/jats:sup> to 24<jats:sup>th<\/jats:sup> months in the CsA group, whereas for the 24<jats:sup>th<\/jats:sup> to 48<jats:sup>th<\/jats:sup> months in both CsA and Tac groups. Hip circumferences percentage changes from the pre-transplant period to the 1<jats:sup>st<\/jats:sup>, 12<jats:sup>th<\/jats:sup> and 24<jats:sup>th<\/jats:sup> months were significantly higher in CsA than in the Tac group. At each time point, there was no significant difference in percentage changes for other anthropometric parameters between the CsA and Tac groups. De novo diabetes mellitus developed in 8.3% of the CsA group and 19.1% of the Tac group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>After a successful kidney transplant, anthropometric measurements increase in most recipients. Although the effect of calcineurin inhibitor type on weight gain is unclear, a regression analysis showed that CNI type was not a risk factor for the development of obesity in the 48<jats:sup>th<\/jats:sup> month. However, it is helpful to be cautious about its dyslipidemic effect in patients using CsA and the potential hazards of using Tac in patients with a diabetic predisposition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-03004-1","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T23:02:19Z","timestamp":1668898939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients"],"prefix":"10.1186","volume":"23","author":[{"given":"Emel Isiktas","family":"Sayilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alparslan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Oruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Ayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Sigirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"12","key":"3004_CR1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1097\/01.tp.0000226070.74443.fb","volume":"81","author":"M Neipp","year":"2006","unstructured":"Neipp M, Karavul B, Jackobs S, et al. Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation. 2006;81(12):1640\u20134. https:\/\/doi.org\/10.1097\/01.tp.0000226070.74443.fb.","journal-title":"Transplantation"},{"issue":"23","key":"3004_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med. 1999;341(23):1725\u201330. https:\/\/doi.org\/10.1056\/NEJM199912023412303.","journal-title":"New Engl J Med"},{"issue":"2","key":"3004_CR3","first-page":"108","volume":"20","author":"JC Hong","year":"2000","unstructured":"Hong JC, Kahan BD. Immunosuppressive agents in organ transplantation: past, present, and future. Semin Nephrol. 2000;20(2):108\u201325.","journal-title":"Semin Nephrol"},{"issue":"10","key":"3004_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1517\/14740338.2015.1083974","volume":"14","author":"P Malvezzi","year":"2015","unstructured":"Malvezzi P, Rostaing L. The safety of calcineurin inhibitors for kidney-transplant patients. Expert Opin Drug Saf. 2015;14(10):1531\u201346. https:\/\/doi.org\/10.1517\/14740338.2015.1083974.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"3004_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/ajkd.2003.50059","volume":"41","author":"AN Friedman","year":"2003","unstructured":"Friedman AN, Miskulin DC, Rosenberg IH, Levey AS. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480\u20137. https:\/\/doi.org\/10.1053\/ajkd.2003.50059.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3004_CR6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1600-6143.2004.00558.x","volume":"4","author":"AP de Vries","year":"2004","unstructured":"de Vries AP, Bakker SJ, van Son WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant. 2004;4(10):1675\u201383. https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00558.x.","journal-title":"Am J Transplant"},{"issue":"12","key":"3004_CR7","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1111\/j.1600-6143.2005.01104.x","volume":"5","author":"D Ducloux","year":"2005","unstructured":"Ducloux D, Kazory A, Simula-Faivre D, Chalopin JM. One-year post-transplant weight gain is a risk factor for graft loss. Am J Transplant. 2005;5(12):2922\u20138. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01104.x.","journal-title":"Am J Transplant"},{"issue":"2","key":"3004_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1600-6143.2005.01198.x","volume":"6","author":"JL Gore","year":"2006","unstructured":"Gore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6(2):357\u201363. https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01198.x.","journal-title":"Am J Transplant"},{"issue":"1","key":"3004_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00007890-200201150-00013","volume":"73","author":"HU Meier-Kriesche","year":"2002","unstructured":"Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73(1):70\u20134. https:\/\/doi.org\/10.1097\/00007890-200201150-00013.","journal-title":"Transplantation"},{"issue":"5","key":"3004_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.jrn.2016.02.007","volume":"26","author":"K Nagy","year":"2016","unstructured":"Nagy K, Ujszaszi A, Remport A, et al. Association of abdominal circumference, body mass index, and inflammation in kidney transplant recipients. J Ren Nutr. 2016;26(5):325\u201333. https:\/\/doi.org\/10.1053\/j.jrn.2016.02.007.","journal-title":"J Ren Nutr"},{"issue":"8","key":"3004_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.tp.0000285290.77406.7b","volume":"84","author":"SH Chang","year":"2007","unstructured":"Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation. 2007;84(8):981\u20137. https:\/\/doi.org\/10.1097\/01.tp.0000285290.77406.7b.","journal-title":"Transplantation"},{"issue":"6","key":"3004_CR12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.transproceed.2018.02.099","volume":"50","author":"S Ma\u0142gorzewicz","year":"2018","unstructured":"Ma\u0142gorzewicz S, Wo\u0142oszyk P, Chamienia A, Jankowska M, D\u0119bska-\u015alizie\u0144 A. Obesity risk factors in patients after kidney transplantation. Transplant Proc. 2018;50(6):1786\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.099.","journal-title":"Transplant Proc"},{"issue":"12","key":"3004_CR13","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/j.1600-6143.2010.03330.x","volume":"10","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy CP, Czira ME, Rudas A, et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant. 2010;10(12):2644\u201351. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03330.x.","journal-title":"Am J Transplant"},{"issue":"1","key":"3004_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1053\/j.ajkd.2008.02.004","volume":"52","author":"FM Sanches","year":"2008","unstructured":"Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis. 2008;52(1):66\u201373. https:\/\/doi.org\/10.1053\/j.ajkd.2008.02.004.","journal-title":"Am J Kidney Dis"},{"issue":"9497","key":"3004_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","volume":"366","author":"S Yusuf","year":"2005","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (London, England). 2005;366(9497):1640\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(05)67663-5.","journal-title":"Lancet (London, England)"},{"issue":"Suppl","key":"3004_CR16","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care. 2015;38(Suppl):S8\u201316.","journal-title":"Diabetes Care"},{"issue":"9","key":"3004_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3004_CR18","doi-asserted-by":"publisher","first-page":"584; author rep","DOI":"10.4065\/mcp.2011.0097","volume":"86","author":"LT Ho-Pham","year":"2011","unstructured":"Ho-Pham LT, Campbell LV, Nguyen TV. More on body fat cutoff points. Mayo Clin Proc. 2011;86(6):584; author reply 584-5. https:\/\/doi.org\/10.4065\/mcp.2011.0097.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"3004_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.ajkd.2008.02.363","volume":"52","author":"EF Elsayed","year":"2008","unstructured":"Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52(1):29\u201338. https:\/\/doi.org\/10.1053\/j.ajkd.2008.02.363.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3004_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.ki.5001628","volume":"70","author":"AM de Mattos","year":"2006","unstructured":"de Mattos AM, Prather J, Olyaei AJ, et al. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 2006;70(4):757\u201364. https:\/\/doi.org\/10.1038\/sj.ki.5001628.","journal-title":"Kidney Int"},{"issue":"2","key":"3004_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/ajkd.2001.26100","volume":"38","author":"JM Clunk","year":"2001","unstructured":"Clunk JM, Lin CY, Curtis JJ. Variables affecting weight gain in renal transplant recipients. Am J Kidney Dis. 2001;38(2):349\u201353. https:\/\/doi.org\/10.1053\/ajkd.2001.26100.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3004_CR22","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.transproceed.2014.09.014","volume":"46","author":"S Ma\u0142gorzewicz","year":"2014","unstructured":"Ma\u0142gorzewicz S, D\u0119bska-Slizie\u0144 A, Czajka B, Rutkowski B. Adipokines and nutritional status in kidney transplant recipients. Transplant Proc. 2014;46(8):2622\u20136. https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.014.","journal-title":"Transplant Proc"},{"issue":"11","key":"3004_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.5603\/KP.a2017.0149","volume":"75","author":"B Jab\u0142onowska-Lietz","year":"2017","unstructured":"Jab\u0142onowska-Lietz B, Wrzosek M, W\u0142odarczyk M, Nowicka G. New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese. Kardiol Pol. 2017;75(11):1185\u201391. https:\/\/doi.org\/10.5603\/KP.a2017.0149.","journal-title":"Kardiol Pol"},{"issue":"25","key":"3004_CR24","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.106.673756","volume":"116","author":"D Canoy","year":"2007","unstructured":"Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007;116(25):2933\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.673756.","journal-title":"Circulation"},{"issue":"5","key":"3004_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurjpc\/zwab038","volume":"29","author":"L Gnatiuc","year":"2022","unstructured":"Gnatiuc L, Tapia-Conyer R, Wade R, et al. Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults. Eur J Prev Cardiol. 2022;29(5):730\u20138. https:\/\/doi.org\/10.1093\/eurjpc\/zwab038.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"3004_CR26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.transproceed.2012.12.009","volume":"45","author":"K Tokodai","year":"2013","unstructured":"Tokodai K, Amada N, Kikuchi H, et al. Body fat percentage as a marker of new-onset diabetes mellitus after kidney transplantation. Transplant Proc. 2013;45(4):1544\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2012.12.009.","journal-title":"Transplant Proc"},{"issue":"5","key":"3004_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1440-1797.2008.00916.x","volume":"13","author":"A Ersoy","year":"2008","unstructured":"Ersoy A, Baran B, Ersoy C, Kahvecioglu S, Akdag I. Calcineurin inhibitors and post-transplant weight gain. Nephrology (Carlton). 2008;13(5):433\u20139. https:\/\/doi.org\/10.1111\/j.1440-1797.2008.00916.x.","journal-title":"Nephrology (Carlton)"},{"issue":"10","key":"3004_CR28","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","volume":"22","author":"C Esteva-Font","year":"2007","unstructured":"Esteva-Font C, Ars E, Guillen-Gomez E, et al. Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant. 2007;22(10):2810\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfm390.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3004_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bcp.2014.01.020","volume":"88","author":"A Furhmann","year":"2014","unstructured":"Furhmann A, Lopes PC, Sereno J, et al. Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model. Biochem Pharmacol. 2014;88(2):216\u201328. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.020.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"3004_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jash.2014.08.010","volume":"8","author":"R Mohebi","year":"2014","unstructured":"Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel predictor of hypertension and cardiovascular disease: results of a decade follow up in a West Asian cohort. J Am Soc Hypertens. 2014;8(11):800\u20137. https:\/\/doi.org\/10.1016\/j.jash.2014.08.010.","journal-title":"J Am Soc Hypertens"},{"issue":"3","key":"3004_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41440-017-0006-0","volume":"41","author":"S Zampetti","year":"2018","unstructured":"Zampetti S, Campagna G, Lucantoni F, et al. Wrist circumference is associated with increased systolic blood pressure in children with overweight\/obesity. Hypertens Res. 2018;41(3):193\u20137. https:\/\/doi.org\/10.1038\/s41440-017-0006-0.","journal-title":"Hypertens Res"},{"issue":"1","key":"3004_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40618-019-01086-7","volume":"43","author":"C Luordi","year":"2020","unstructured":"Luordi C, Maddaloni E, Bizzarri C, et al. Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity. J Endocrinol Invest. 2020;43(1):101\u20137. https:\/\/doi.org\/10.1007\/s40618-019-01086-7.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"3004_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40519-018-0534-x","volume":"25","author":"N Namazi","year":"2020","unstructured":"Namazi N, Djalalinia S, Mahdavi-Gorabi A, et al. Association of wrist circumference with cardio-metabolic risk factors: a systematic review and meta-analysis. Eat Weight Disord. 2020;25(1):151\u201361. https:\/\/doi.org\/10.1007\/s40519-018-0534-x.","journal-title":"Eat Weight Disord"},{"issue":"5","key":"3004_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajhb.22416","volume":"25","author":"NT Mueller","year":"2013","unstructured":"Mueller NT, Johnson W, Odegaard AO, et al. Wrist breadth and homeostasis model assessment of insulin resistance in youth: the Fels Longitudinal Study. Am J Hum Biol. 2013;25(5):581\u20135. https:\/\/doi.org\/10.1002\/ajhb.22416.","journal-title":"Am J Hum Biol"},{"issue":"3","key":"3004_CR35","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/ndt\/gfp566","volume":"25","author":"HA Bergrem","year":"2010","unstructured":"Bergrem HA, Valderhaug TG, Hartmann A, et al. Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant. 2010;25(3):985\u201392. https:\/\/doi.org\/10.1093\/ndt\/gfp566.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"3004_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.asn.0000048717.97169.29","volume":"14","author":"E Gotti","year":"2003","unstructured":"Gotti E, Perico N, Perna A, et al. Renal transplantation: can we reduce calcineurin inhibitor\/stop steroids? Evidence based on protocol biopsy findings. J Am Soc Nephrol. 2003;14(3):755\u201366. https:\/\/doi.org\/10.1097\/01.asn.0000048717.97169.29.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3004_CR37","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/ATVBAHA.115.307030","volume":"36","author":"M Kockx","year":"2016","unstructured":"Kockx M, Glaros E, Leung B, et al. Low-density lipoprotein receptor-dependent and low-density lipoprotein receptor-independent mechanisms of cyclosporin A-induced dyslipidemia. Arterioscler Thromb Vasc Biol. 2016;36(7):1338\u201349. https:\/\/doi.org\/10.1161\/ATVBAHA.115.307030.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 2","key":"3004_CR38","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.2215\/CJN.02650707","volume":"3 Suppl 2","author":"RD Bloom","year":"2008","unstructured":"Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol. 2008;3 Suppl 2(Suppl 2):S38-48. https:\/\/doi.org\/10.2215\/CJN.02650707.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3004_CR39","doi-asserted-by":"publisher","first-page":"e130770","DOI":"10.1172\/jci.insight.130770","volume":"5","author":"C Dai","year":"2020","unstructured":"Dai C, Walker JT, Shostak A, et al. Tacrolimus- and sirolimus-induced human \u03b2 cell dysfunction is reversible and preventable. JCI Insight. 2020;5(1):e130770. https:\/\/doi.org\/10.1172\/jci.insight.130770.","journal-title":"JCI Insight"},{"issue":"3","key":"3004_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/14779072.6.3.343","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays HE, Gonz\u00e1lez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343\u201368. https:\/\/doi.org\/10.1586\/14779072.6.3.343.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"3004_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1034\/j.1399-0012.2002.02059.x","volume":"16","author":"J Hjelmesaeth","year":"2002","unstructured":"Hjelmesaeth J, Hagen M, Hartmann A, et al. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant. 2002;16(6):389\u201396. https:\/\/doi.org\/10.1034\/j.1399-0012.2002.02059.x.","journal-title":"Clin Transplant"},{"issue":"3","key":"3004_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/tri.12907.38","volume":"30","author":"MB J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen MB, Hornum M, van Hall G, et al. The impact of kidney transplantation on insulin sensitivity. Transpl Int. 2017;30(3):295\u2013304. https:\/\/doi.org\/10.1111\/tri.12907.38.","journal-title":"Transpl Int"},{"issue":"3","key":"3004_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00007890-199908150-00012","volume":"68","author":"CB Drachenberg","year":"1999","unstructured":"Drachenberg CB, Klassen DK, Weir MR, et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation. 1999;68(3):396\u2013402. https:\/\/doi.org\/10.1097\/00007890-199908150-00012.","journal-title":"Transplantation"},{"issue":"1","key":"3004_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0272-6386(99)70101-0","volume":"34","author":"MR Weir","year":"1999","unstructured":"Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1\u201313. https:\/\/doi.org\/10.1016\/s0272-6386(99)70101-0.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3004_CR45","first-page":"778","volume":"294","author":"ND Vaziri","year":"2000","unstructured":"Vaziri ND, Liang K, Azad H. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. J Pharmacol Exp Ther. 2000;294(2):778\u201383.","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"3004_CR46","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1016\/j.transproceed.2010.07.009","volume":"42","author":"M Allamani","year":"2010","unstructured":"Allamani M, Sennesael J, Vendemeulenbroucke E. Posttransplantation diabetes mellitus: a long-term retrospective cohort study. Transplant Proc. 2010;42(10):4378\u201383. https:\/\/doi.org\/10.1016\/j.transproceed.2010.07.009.","journal-title":"Transplant Proc"},{"key":"3004_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/DMSO.S19027","volume":"4","author":"PT Pham","year":"2011","unstructured":"Pham PT, Pham PM, Pham SV, Pham PA, Pham PC. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes. 2011;4:175\u201386. https:\/\/doi.org\/10.2147\/DMSO.S19027.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7191","key":"3004_CR48","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","volume":"318","author":"GA Knoll","year":"1999","unstructured":"Knoll GA, Bell RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ (Clinical research ed). 1999;318(7191):1104\u20137. https:\/\/doi.org\/10.1136\/bmj.318.7191.1104.","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"3004_CR49","doi-asserted-by":"publisher","first-page":"E1885","DOI":"10.1210\/jc.2014-1266","volume":"99","author":"MJ Pereira","year":"2014","unstructured":"Pereira MJ, Palming J, Rizell M, et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. J Clin Endocrinol Metab. 2014;99(10):E1885\u201394. https:\/\/doi.org\/10.1210\/jc.2014-1266.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"3004_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11010-017-3261-0","volume":"445","author":"ACRG Fonseca","year":"2018","unstructured":"Fonseca ACRG, Carvalho E, Eriksson JW, Pereira MJ. Calcineurin is an important factor involved in glucose uptake in human adipocytes. Mol Cell Biochem. 2018;445(1\u20132):157\u201368. https:\/\/doi.org\/10.1007\/s11010-017-3261-0.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"3004_CR51","doi-asserted-by":"publisher","first-page":"e0243394","DOI":"10.1371\/journal.pone.0243394","volume":"15","author":"CC Forte","year":"2020","unstructured":"Forte CC, Pedrollo EF, Nicoletto BB, et al. Risk factors associated with weight gain after kidney transplantation: a cohort study. PLoS One. 2020;15(12):e0243394. https:\/\/doi.org\/10.1371\/journal.pone.0243394.","journal-title":"PLoS One"},{"issue":"6","key":"3004_CR52","doi-asserted-by":"publisher","first-page":"e0268044","DOI":"10.1371\/journal.pone.0268044","volume":"17","author":"A Altheaby","year":"2022","unstructured":"Altheaby A, Alajlan N, Shaheen MF, et al. Weight gain after renal transplant: Incidence, risk factors, and outcomes. PLoS One. 2022;17(6):e0268044. https:\/\/doi.org\/10.1371\/journal.pone.0268044.","journal-title":"PLoS One"},{"issue":"6","key":"3004_CR53","first-page":"356","volume":"49","author":"MJ Mihatsch","year":"1998","unstructured":"Mihatsch MJ, Kyo M, Morozumi K, et al. The side-effects of cyclosporine-A and tacrolimus. Clin Nephrol. 1998;49(6):356\u201363.","journal-title":"Clin Nephrol"},{"issue":"3","key":"3004_CR54","first-page":"170","volume":"9","author":"S Alghamdi","year":"2011","unstructured":"Alghamdi S, Nabi Z, Skolnik E, Alkorbi L, Albaqumi M. Cyclosporine versus tacrolimus maintenance therapy in renal transplant. Exp Clin Transplant. 2011;9(3):170\u20134.","journal-title":"Exp Clin Transplant"},{"issue":"11","key":"3004_CR55","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1097\/01.asn.0000095250.92361.d5","volume":"14","author":"B Kaplan","year":"2003","unstructured":"Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003;14(11):2980\u20134. https:\/\/doi.org\/10.1097\/01.asn.0000095250.92361.d5.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3004_CR56","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00007890-200203150-00021","volume":"73","author":"F Vincenti","year":"2002","unstructured":"Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation. 2002;73(5):775\u201382. https:\/\/doi.org\/10.1097\/00007890-200203150-00021.","journal-title":"Transplantation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-03004-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T23:02:58Z","timestamp":1668898978000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-03004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-03004-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by Uludag University Faculty of Medicine Clinical Research Ethics Committee [Date of Approval: 12\/08\/2014; Reference number\/Protocol No: 2014\u201315\/20].Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"375"}}